AstaTech, Inc. logo — A US based CRO/CMO specialized on advanced intermediates, cu...

AstaTech, Inc.

A US based CRO/CMO specialized on advanced intermediates, custom synthesis and FTE from lab scale to mass production.

Founded 1996 United States Bristol, United States 39 employees Series B Total: $200.00M

General Information

Company Name AstaTech, Inc.
Founded Year 1996
Location United States Bristol, United States
Employees 39
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with AstaTech, Inc.. To contact AstaTech, Inc., visit astatechinc.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does AstaTech, Inc. compare?

A PDF of AstaTech, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting AstaTech, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About AstaTech, Inc.

AstaTech, Inc. is a US based CRO/CMO specializing in advanced intermediates, custom synthesis, and FTE from lab scale to mass production. Founded in 1996 by former scientists from leading pharmaceutical companies, AstaTech is one of the earliest chemistry CRO companies in the United States. With over 100 chemists, 40% holding PH.D or MS degrees, the company serves 10,000 customers worldwide. It offers over 100,000 advanced intermediates and drug-like building blocks, with 10% of its products being scalable to kg/MT scales. AstaTech's expertise and manufacturing capabilities enable it to deliver high-quality chemistry solutions from drug discovery to manufacturing at competitive costs. The latest investment of CNY200.00M in a Series B round took place on 29 July 2022 and was led by Shenyin & Wanguo Investment.

Business keywords: CRO, CMO, chemistry, intermediates, custom synthesis, FTE, drug discovery, pharmaceutical, scale-up

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series B CNY200.00M 1
Shenyin & Wanguo Investment
29 Jul 2022

AstaTech, Inc. Alternatives & Competitors

View All Alternatives
AstaTech, Inc. vs

Full-service CRO-CDMO with a vision to propel the launch of 25 new medicines by 2025.

Venture round
3394 employees
Health Care, Pharmaceutical
AstaTech, Inc. vs

Now part of Fortis Life Sciences providing nanoparticles, contract development, and scaled manufactu...

49 employees
Information Technology
AstaTech, Inc. vs
Granlen
Granlen United States

Nucleosides

2 employees
Manufacturing, Pharmaceutical

FAQ About AstaTech, Inc.

A US based CRO/CMO specialized on advanced intermediates, custom synthesis and FTE from lab scale to mass production.
AstaTech, Inc. was founded in 1996.
AstaTech, Inc. is headquartered in Bristol, United States.
AstaTech, Inc. has approximately 39 employees.
AstaTech, Inc. has completed 1 funding round, raising a total of $200.00M. The latest funding stage is Series B.
Top alternatives and competitors to AstaTech, Inc. include Sai Life Sciences Ltd, nanoComposix | Fortis Life Sciences, Granlen, Specs, part of eMolecules, Inc., Nitto Avecia. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
AstaTech, Inc. and Sai Life Sciences Ltd are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for AstaTech, Inc., https://bouncewatch.com/company/astatech-inc, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes